These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37307219)

  • 1. Structure-guided discovery of adenosine triphosphate-competitive casein kinase 2 inhibitors.
    Patel S; Vyas VK; Sharma M; Ghate M
    Future Med Chem; 2023 Jun; 15(11):987-1014. PubMed ID: 37307219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of chemical linchpins for highly selective CK2α targeting.
    Greco FA; Krämer A; Wahl L; Elson L; Ehret TAL; Gerninghaus J; Möckel J; Müller S; Hanke T; Knapp S
    Eur J Med Chem; 2024 Oct; 276():116672. PubMed ID: 39067440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATP site-directed inhibitors of protein kinase CK2: an update.
    Sarno S; Papinutto E; Franchin C; Bain J; Elliott M; Meggio F; Kazimierczuk Z; Orzeszko A; Zanotti G; Battistutta R; Pinna LA
    Curr Top Med Chem; 2011; 11(11):1340-51. PubMed ID: 21513497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.
    Cozza G; Sarno S; Ruzzene M; Girardi C; Orzeszko A; Kazimierczuk Z; Zagotto G; Bonaiuto E; Di Paolo ML; Pinna LA
    Biochim Biophys Acta; 2013 Jul; 1834(7):1402-9. PubMed ID: 23360763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
    Raaf J; Brunstein E; Issinger OG; Niefind K
    Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dark side of protein kinase CK2 inhibition.
    Cozza G; Meggio F; Moro S
    Curr Med Chem; 2011; 18(19):2867-84. PubMed ID: 21651492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
    Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
    J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.
    Cozza G; Mazzorana M; Papinutto E; Bain J; Elliott M; di Maira G; Gianoncelli A; Pagano MA; Sarno S; Ruzzene M; Battistutta R; Meggio F; Moro S; Zagotto G; Pinna LA
    Biochem J; 2009 Jul; 421(3):387-95. PubMed ID: 19432557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of 2-amino-6-methyl-pyrimidine benzoic acids as ATP competitive casein kinase-2 (CK2) inhibitors using structure- and fragment-based design, docking and molecular dynamic simulation studies.
    Patel S; Patel S; Tulsian K; Kumar P; Vyas VK; Ghate M
    SAR QSAR Environ Res; 2023 Mar; 34(3):211-230. PubMed ID: 37051759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of protein kinase CK2 by flavonoids and tyrphostins. A structural insight.
    Lolli G; Cozza G; Mazzorana M; Tibaldi E; Cesaro L; Donella-Deana A; Meggio F; Venerando A; Franchin C; Sarno S; Battistutta R; Pinna LA
    Biochemistry; 2012 Aug; 51(31):6097-107. PubMed ID: 22794353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinase CK2 inhibition: an update.
    Cozza G; Pinna LA; Moro S
    Curr Med Chem; 2013; 20(5):671-93. PubMed ID: 23210774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.
    Battistutta R
    Cell Mol Life Sci; 2009 Jun; 66(11-12):1868-89. PubMed ID: 19387547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downfalls of Chemical Probes Acting at the Kinase ATP-Site: CK2 as a Case Study.
    Atkinson EL; Iegre J; Brear PD; Zhabina EA; Hyvönen M; Spring DR
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33807474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the design of bisubstrate inhibitors of protein kinase CK2 provided by complex structures with the substrate-competitive inhibitor heparin.
    Schnitzler A; Niefind K
    Eur J Med Chem; 2021 Mar; 214():113223. PubMed ID: 33571828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
    Gyenis L; Turowec JP; Bretner M; Litchfield DW
    Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
    Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and functional determinants of protein kinase CK2α: facts and open questions.
    Battistutta R; Lolli G
    Mol Cell Biochem; 2011 Oct; 356(1-2):67-73. PubMed ID: 21739155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features and potentials of ATP-site directed CK2 inhibitors.
    Sarno S; Salvi M; Battistutta R; Zanotti G; Pinna LA
    Biochim Biophys Acta; 2005 Dec; 1754(1-2):263-70. PubMed ID: 16198160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies of Targeting CK2 in Drug Discovery: Challenges, Opportunities, and Emerging Prospects.
    Chen Y; Wang Y; Wang J; Zhou Z; Cao S; Zhang J
    J Med Chem; 2023 Feb; 66(4):2257-2281. PubMed ID: 36745746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule modulators targeting protein kinase CK1 and CK2.
    Qiao Y; Chen T; Yang H; Chen Y; Lin H; Qu W; Feng F; Liu W; Guo Q; Liu Z; Sun H
    Eur J Med Chem; 2019 Nov; 181():111581. PubMed ID: 31400711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.